Tarsus Pharmaceuticals (NASDAQ:TARS – Free Report) had its price objective raised by Oppenheimer from $63.00 to $65.00 in a research note released on Thursday morning,Benzinga reports. They currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback